22 related articles for article (PubMed ID: 15305155)
1. Melan-A expression in non-melanocytic carcinoma: A potential diagnostic pitfall.
Zuo L; You H; Cai Z; Liao S; Lu X; Li L; Huang W
Histol Histopathol; 2023 Dec; ():18696. PubMed ID: 38205829
[TBL] [Abstract][Full Text] [Related]
2. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
[TBL] [Abstract][Full Text] [Related]
3. Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review.
Oryani MA; Nosrati S; Javid H; Mehri A; Hashemzadeh A; Karimi-Shahri M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1377-1404. PubMed ID: 37715816
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells.
Fankhauser R; Chang M; Garrison Z; Berryman R; Lucero OM; Fuiten A; DePatie N; Seifert H; Kulkarni RP
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230844
[TBL] [Abstract][Full Text] [Related]
5. HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
Ma J; Han H; Liu D; Li W; Feng H; Xue X; Wu X; Niu G; Zhang G; Zhao Y; Liu C; Tao H; Gao B
PLoS One; 2013; 8(8):e73261. PubMed ID: 24015299
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte responses against melanocytes and melanoma.
Chang GY; Kohrt HE; Stuge TB; Schwartz EJ; Weber JS; Lee PP
J Transl Med; 2011 Jul; 9():122. PubMed ID: 21794122
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.
Douat-Casassus C; Borbulevych O; Tarbe M; Gervois N; Jotereau F; Baker BM; Quideau S
J Med Chem; 2010 Oct; 53(19):7061-6. PubMed ID: 20806940
[TBL] [Abstract][Full Text] [Related]
8. Isolation, establishment, and characterization of ex vivo equine melanoma cell cultures.
Chapman SW; Metzger N; Grest P; Feige K; von Rechenberg B; Auer JA; Hottiger MO
In Vitro Cell Dev Biol Anim; 2009; 45(3-4):152-62. PubMed ID: 19057970
[TBL] [Abstract][Full Text] [Related]
9. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
[TBL] [Abstract][Full Text] [Related]
10. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.
Murer K; Urosevic M; Willers J; Selvam P; Laine E; Burg G; Dummer R
Melanoma Res; 2004 Aug; 14(4):257-62. PubMed ID: 15305155
[TBL] [Abstract][Full Text] [Related]
11. Expression of melanoma-associated antigens in melanoma cell cultures.
Urosevic M; Braun B; Willers J; Burg G; Dummer R
Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
[TBL] [Abstract][Full Text] [Related]
12. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
13. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
Strohal R; Mosser R; Kittler H; Wolff K; Jansen B; Brna C; Stingl G; Pehamberger H
Melanoma Res; 2001 Oct; 11(5):543-8. PubMed ID: 11595894
[TBL] [Abstract][Full Text] [Related]
14. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
